Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06021288

Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )

Led by Universität Münster · Updated on 2024-11-27

165

Participants Needed

2

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Acute kidney injury (AKI) is a well-recognized complication in critically ill patients, which often leads to the necessity of mechanical kidney support (CRRT). In current therapeutic regimes, CRRT is used to strictly prevent azotaemia. Thus recent clinical observations, as well as data from animal testing suggest a link between controlled azotaemia and faster renal recovery in AKI patients. The aim of the study is to improve renal recovery.

CONDITIONS

Official Title

Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (age �3e=18 years)
  • Critically ill patients with acute kidney injury needing continuous renal replacement therapy
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Chronic dialysis dependency
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) less than 30 ml/min/1.73m�b2
  • Severe liver cirrhosis (Child-Pugh C)
  • Severe acidosis (pH less than 7.20 at study enrollment)
  • Severe hyperkalaemia (greater than 6 mmol/l)
  • Pregnancy or breastfeeding
  • Persons held in an institution by legal or official order
  • Dependency on the investigator or center

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University Hospital Münster

Münster, Germany, 48149

Actively Recruiting

2

Universitätsklinikum Tübingen; Universitätsklinik für Anästhesiologie und Intensivmedizin

Tübingen, Germany, 72076

Actively Recruiting

Loading map...

Research Team

A

Alexander Zarbock, MD

CONTACT

M

Melanie Meersch-Dini, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here